Update on Medical Management of Clinical Manifestations of Chronic Kidney Disease

      Keywords

      To read this article in full you will need to make a payment
      Purchase one-time access
      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
      Content published before 2002 is available via pay-per-view purchase only.
      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jepson R.E.
        Feline systemic hypertension: classification and pathogenesis.
        J Feline Med Surg. 2011; 13: 25-34
        • Jacob F.
        • Polzin D.J.
        • Osborne C.A.
        • et al.
        Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure.
        J Am Vet Med Assoc. 2003; 222: 322-329
        • Wehner A.
        • Hartmann K.
        • Hirschberger J.
        Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non-renal diseases.
        Vet Rec. 2008; 162: 141-147
        • Brown S.
        • Atkins C.
        • Bagley R.
        • et al.
        Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.
        J Vet Intern Med. 2007; 21: 542-558
        • Maggio F.
        • DeFrancesco T.C.
        • Atkins C.E.
        • et al.
        Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998).
        J Am Vet Med Assoc. 2000; 217: 695-702
        • Bartges J.W.
        Chronic kidney disease in dogs and cats.
        Vet Clin North Am Small Anim Pract. 2012; 42 (vi): 669-692
        • Henik R.A.
        • Stepien R.L.
        • Bortnowski H.B.
        Spectrum of M-mode echocardiographic abnormalities in 75 cats with systemic hypertension.
        J Am Anim Hosp Assoc. 2004; 40: 359-363
        • Bijsmans E.S.
        • Jepson R.E.
        • Chang Y.M.
        • et al.
        Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease.
        J Vet Intern Med. 2015; 29: 855-861
        • Bragg R.F.
        • Bennett J.S.
        • Cummings A.
        • et al.
        Evaluation of the effects of hospital visit stress on physiologic variables in dogs.
        J Am Vet Med Assoc. 2015; 246: 212-215
        • Quimby J.M.
        • Smith M.L.
        • Lunn K.F.
        Evaluation of the effects of hospital visit stress on physiologic parameters in the cat.
        J Feline Med Surg. 2011; 13: 733-737
        • Polzin D.J.
        Evidence-based step-wise approach to managing chronic kidney disease in dogs and cats.
        J Vet Emerg Crit Care. 2013; 23: 205-215
        • Huhtinen M.
        • Derre G.
        • Renoldi H.J.
        • et al.
        Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats.
        J Vet Intern Med. 2015; 29: 786-793
        • Polzin D.J.
        Chronic kidney disease in small animals.
        Vet Clin North Am Small Anim Pract. 2011; 41: 15-30
        • Jepson R.E.
        • Elliott J.
        • Brodbelt D.
        • et al.
        Effect of control of systolic blood pressure on survival in cats with systemic hypertension.
        J Vet Intern Med. 2007; 21: 402-409
        • Jepson R.E.
        • Syme H.M.
        • Elliott J.
        Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.
        J Vet Intern Med. 2014; 28: 144-153
        • Syme H.
        Hypertension in small animal kidney disease.
        Vet Clin North Am Small Anim Pract. 2011; 41: 63-89
        • Helms S.R.
        Treatment of feline hypertension with transdermal amlodipine: a pilot study.
        J Am Anim Hosp Assoc. 2007; 43: 149-156
        • Brown S.
        • Elliott J.
        • Francey T.
        • et al.
        Consensus recommendations for standard therapy of glomerular disease in dogs.
        J Vet Intern Med. 2013; 27: S27-S43
        • DiBartola S.P.
        • Rutgers H.C.
        • Zack P.M.
        • et al.
        Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984).
        J Am Vet Med Assoc. 1987; 190: 1196-1202
        • Elliott J.
        • Barber P.J.
        Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995.
        J Small Anim Pract. 1998; 39: 78-85
        • Nakhoul G.N.
        • Huang H.
        • Arrigain S.
        • et al.
        Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
        Am J Nephrol. 2015; 41: 456-463
        • Korgaonkar S.
        • Tilea A.
        • Gillespie B.W.
        • et al.
        Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.
        Clin J Am Soc Nephrol. 2010; 5: 762-769
        • Reungjui S.
        • Roncal C.A.
        • Sato W.
        • et al.
        Hypokalemic nephropathy is associated with impaired angiogenesis.
        J Am Soc Nephrol. 2008; 19: 125-134
        • Buffington C.A.
        • DiBartola S.P.
        • Chew D.J.
        Effect of low potassium commercial nonpurified diet on renal function of adult cats.
        J Nutr. 1991; 121: S91-S92
        • Adams L.G.
        • Polzin D.J.
        • Osborne C.A.
        • et al.
        Effects of dietary protein and calorie restriction in clinically normal cats and in cats with surgically induced chronic renal failure.
        Am J Vet Res. 1993; 54: 1653-1662
        • Chakrabarti S.
        • Syme H.M.
        • Elliott J.
        Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease.
        J Vet Intern Med. 2012; 26: 275-281
        • King J.N.
        • Tasker S.
        • Gunn-Moore D.A.
        • et al.
        Prognostic factors in cats with chronic kidney disease.
        J Vet Intern Med. 2007; 21: 906-916
        • Forrester S.D.
        • Adams L.G.
        • Allen T.A.
        Chronic kidney disease.
        in: Thatcher C.D. Remillard R.L. Small animal clinical nutrition. 5th edition. Mark Morris Institute, Topeka (KS)2010: 765-810
        • Theisen S.K.
        • DiBartola S.P.
        • Radin M.J.
        • et al.
        Muscle potassium content and potassium gluconate supplementation in normokalemic cats with naturally occurring chronic renal failure.
        J Vet Intern Med. 1997; 11: 212-217
        • Sparkes A.H.
        • Caney S.M.
        • Chalhoub S.
        • et al.
        ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease.
        J Feline Med Surg. 2016; 18: 219-239
        • Dow S.W.
        • LeCouteur R.A.
        • Fettman M.J.
        • et al.
        Potassium depletion in cats: hypokalemic polymyopathy.
        J Am Vet Med Assoc. 1987; 191: 1563-1568
        • Chalhoub S.
        • Langston C.
        • Eatroff A.
        Anemia of renal disease: what it is, what to do and what's new.
        J Feline Med Surg. 2011; 13: 629-640
        • McLeland S.M.
        • Lunn K.F.
        • Duncan C.G.
        • et al.
        Relationship among serum creatinine, serum gastrin, calcium-phosphorus product, and uremic gastropathy in cats with chronic kidney disease.
        J Vet Intern Med. 2014; 28: 827-837
        • Gest J.
        • Langston C.
        • Eatroff A.
        Iron status of cats with chronic kidney disease.
        J Vet Intern Med. 2015; 29: 1488-1493
        • Nangaku M.
        Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.
        J Am Soc Nephrol. 2006; 17: 17-25
        • Chalhoub S.
        • Langston C.E.
        • Farrelly J.
        The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases.
        J Vet Intern Med. 2012; 26: 363-369
        • Markovich J.E.
        • Freeman L.M.
        • Labato M.A.
        • et al.
        Survey of dietary and medication practices of owners of cats with chronic kidney disease.
        J Feline Med Surg. 2015; 17: 979-983
        • Neyra R.
        • Chen K.Y.
        • Sun M.
        • et al.
        Increased resting energy expenditure in patients with end-stage renal disease.
        JPEN J Parenter Enteral Nutr. 2003; 27: 36-42
        • Carrero J.J.
        • Stenvinkel P.
        • Cuppari L.
        • et al.
        Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM).
        J Ren Nutr. 2013; 23: 77-90
        • Parker V.J.
        • Freeman L.M.
        Association between body condition and survival in dogs with acquired chronic kidney disease.
        J Vet Intern Med. 2011; 25: 1306-1311
        • Freeman L.
        • Lachaud M.P.
        • Matthews S.
        • et al.
        Evaluation of weight loss over time in cats with chronic kidney disease.
        J Vet Intern Med. 2015; 29: 1272
        • Bijsmans E.S.
        • Jepson R.E.
        • Syme H.M.
        • et al.
        Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease.
        J Vet Intern Med. 2016; 30: 183-191
        • Reynolds C.A.
        • Oyama M.A.
        • Rush J.E.
        • et al.
        Perceptions of quality of life and priorities of owners of cats with heart disease.
        J Vet Intern Med. 2010; 24: 1421-1426
        • Borison H.L.
        • Hebertson L.M.
        Role of medullary emetic chemoreceptor trigger zone (CT zone) in postnephrectomy vomiting in dogs.
        Am J Physiol. 1959; 197: 850-852
        • Goldstein R.E.
        • Marks S.L.
        • Kass P.H.
        • et al.
        Gastrin concentrations in plasma of cats with chronic renal failure.
        J Am Vet Med Assoc. 1998; 213: 826-828
        • Liptak J.M.
        • Hunt G.B.
        • Barrs V.R.
        • et al.
        Gastroduodenal ulceration in cats: eight cases and a review of the literature.
        J Feline Med Surg. 2002; 4: 27-42
        • El Ghonaimy E.
        • Barsoum R.
        • Soliman M.
        • et al.
        Serum gastrin in chronic renal failure: morphological and physiological correlations.
        Nephron. 1985; 39: 86-94
        • Gunta S.S.
        • Mak R.H.
        Ghrelin and leptin pathophysiology in chronic kidney disease.
        Pediatr Nephrol. 2013; 28: 611-616
        • Freeman L.
        • Becvarova I.
        • Cave N.
        • et al.
        WSAVA nutritional assessment guidelines.
        Compend Contin Educ Vet. 2011; 33: E1-E9
        • Michel K.E.
        • Anderson W.
        • Cupp C.
        • et al.
        Correlation of a feline muscle mass score with body composition determined by dual-energy X-ray absorptiometry.
        Br J Nutr. 2011; 106: S57-S59
        • Hutchinson D.
        • Sutherland-Smith J.
        • Watson A.L.
        • et al.
        Assessment of methods of evaluating sarcopenia in old dogs.
        Am J Vet Res. 2012; 73: 1794-1800
        • Hickman M.A.
        • Cox S.R.
        • Mahabir S.
        • et al.
        Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats.
        J Vet Pharmacol Ther. 2008; 31: 220-229
        • Quimby J.M.
        • Brock W.T.
        • Moses K.
        • et al.
        Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded placebo-controlled clinical trial.
        J Feline Med Surg. 2014; 17: 692-697
        • Quimby J.M.
        • Lake R.C.
        • Hansen R.J.
        • et al.
        Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy cats.
        J Vet Pharmacol Ther. 2014; 37: 348-353
        • Saynor D.A.
        • Dixon C.M.
        The metabolism of ondansetron.
        Eur J Cancer Clin Oncol. 1989; 25: S75-S77
        • Zajic L.B.
        • Herndon A.
        • Sieberg L.
        • et al.
        Investigation of the pharmacokinetics of transdermal ondansetron in normal purpose-bred cats.
        J Vet Intern Med. 2016; 30: TBD
        • Herndon A.
        • Sieberg L.
        • Davis L.
        • et al.
        Pharmacokinetics of intravenous and subcutaneous dolasetron and pharmacodynamics of subcutaneous dolasetron in purpose-bred cats.
        J Vet Intern Med. 2016; 30: TBD
        • Timmer C.J.
        • Sitsen J.M.
        • Delbressine L.P.
        Clinical pharmacokinetics of mirtazapine.
        Clin Pharmacokinet. 2000; 38: 461-474
        • Kast R.E.
        • Foley K.F.
        Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
        Eur J Cancer Care (Engl). 2007; 16: 351-354
        • Pae C.U.
        Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting.
        Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30: 1143-1145
        • Quimby J.M.
        • Lunn K.F.
        Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: A masked placebo-controlled crossover clinical trial.
        Vet J. 2013; 197: 651-655
        • Giorgi M.
        • Yun H.
        Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: a pilot study.
        Vet J. 2012; 192: 239-241
        • Quimby J.M.
        • Gustafson D.L.
        • Lunn K.F.
        The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats.
        J Vet Intern Med. 2011; 25: 985-989
        • Quimby J.M.
        • Gustafson D.L.
        • Samber B.J.
        • et al.
        Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats.
        J Vet Pharmacol Ther. 2011; 34: 388-396
        • Ferguson L.E.
        • McLean M.K.
        • Bates J.A.
        • et al.
        Mirtazapine toxicity in cats: retrospective study of 84 cases (2006-2011).
        J Feline Med Surg. 2015; ([Epub ahead of print])
        • Benson K.K.
        • Zajic L.B.
        • Lunghofer P.J.
        • et al.
        Pharmacodynamics of transdermal mirtazapine in healthy client-owned cats.
        J Vet Int Med. 2015; 29: 1225
        • Zollers B.
        • Allen J.
        • Kennedy C.
        • et al.
        Capromorelin, an orally active ghrelin agonist, caused sustained increases in IGF-1, increased food intake and body weight in cats.
        J Vet Intern Med. 2015; 29: 1219
        • Zollers B.
        • Rhodes L.
        Capromorelin, an orally active ghrelin agonist, stimulates appetite and weight gain in inappetent dogs in a multi-site field study.
        J Vet Intern Med. 2014; 28: 1032
        • Zollers B.
        • Rhodes L.
        Capromorelin, an orally active ghrelin agonist, stimulates growth hormone, sustained increases in IGF-1, increased food intake and weight gain in beagle dogs.
        J Vet Intern Med. 2014; 28: 1034
        • Parkinson S.
        • Tolbert K.
        • Messenger K.
        • et al.
        Evaluation of the Effect of Orally Administered Acid Suppressants On Intragastric pH in Cats.
        J Vet Intern Med. 2015; 29: 104-112
        • Sutalo S.
        • Ruetten M.
        • Hartnack S.
        • et al.
        The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
        J Vet Intern Med. 2015; 29: 840-846
        • Lazarus B.
        • Chen Y.
        • Wilson F.P.
        • et al.
        Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
        JAMA Intern Med. 2016; 176: 238-246
        • Michel K.E.
        Management of anorexia in the cat.
        J Feline Med Surg. 2001; 3: 3-8
        • Chan D.L.
        The Inappetent Hospitalised Cat: clinical approach to maximising nutritional support.
        J Feline Med Surg. 2009; 11: 925-933
        • Chen J.Z.
        • Deng A.W.
        • Xu J.F.
        Electroenterogram manifestations and significance in hypokalemia.
        Di Yi Jun Yi Da Xue Xue Bao. 2005; 25: 7-9
        • Kidder A.C.
        • Chew D.
        Treatment options for hyperphosphatemia in feline CKD: what's out there?.
        J Feline Med Surg. 2009; 11: 913-924
        • Quimby J.M.
        • Lappin M.R.
        Evaluating sucralfate as a phosphate binder in normal cats and cats with chronic kidney disease.
        J Am Anim Hosp Assoc. 2016; 52: 8-12
        • Tam F.M.
        • Carr A.P.
        • Myers S.L.
        Safety and palatability of polyethylene glycol 3350 as an oral laxative in cats.
        J Feline Med Surg. 2011; 13: 694-697
        • Freiche V.
        • Houston D.
        • Weese H.
        • et al.
        Uncontrolled study assessing the impact of a psyllium-enriched extruded dry diet on faecal consistency in cats with constipation.
        J Feline Med Surg. 2011; 13: 903-911
        • LeGrange S.N.
        • Boothe D.M.
        • Herndon S.
        • et al.
        Pharmacokinetics and suggested oral dosing regimen of cisapride: a study in healthy cats.
        J Am Anim Hosp Assoc. 1997; 33: 517-523
        • Washabau R.J.
        • Sammarco J.
        Effects of cisapride on feline colonic smooth muscle function.
        Am J Vet Res. 1996; 57: 541-546
        • KuKanich B.
        Outpatient oral analgesics in dogs and cats beyond nonsteroidal antiinflammatory drugs: an evidence-based approach.
        Vet Clin North Am Small Anim Pract. 2013; 43: 1109-1125